)
)
Nkarta Investor Relations Material
Latest events
FDA Announcement
Nkarta
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Nkarta Inc
Access all reports
Nkarta Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel allogeneic, off-the-shelf engineered natural killer (NK) cell therapies for the treatment of cancer. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Nkarta Inc
Corporate Presentation
Nkarta Inc
Corporate Presentation
Nkarta Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
NKTX
Country
🇺🇸 United States